Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

First clinical data presented for BGB-A333 in patients with solid tumors

July 6, 2020

Enrollment underway in phase I study of EPI-7386 for metastatic castration-resistant prostate cancer

July 6, 2020

Ideaya Biosciences discovers MAT2A inhibitors

July 6, 2020

Novel curcumin-peptide conjugate demonstrates efficacy in SORT1-positive cancer models

July 6, 2020

Discovery of novel highly potent Mcl-1 inhibitor, APG-3526

July 6, 2020

Tumor stroke-inducing nanoparticles effective in animals

July 6, 2020

First-in-human study evaluates metarrestin in metastatic solid tumors

July 3, 2020

Discovery and preclinical evaluation of potent FLT3/AXL dual inhibitor, JR-F104

July 3, 2020

First patient dosed in phase II study of ICP-192 for cholangiocarcinoma

July 3, 2020

Heptares Therapeutics identifies new orexin OX1 receptor antagonists

July 3, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...